本页面由Tiger Trade Technology Pte. Ltd.提供服务

IGM Biosciences

1.27
0.0000
成交量:- -
成交额:206.61万
市值:7,657.17万
市盈率:-1.44
高:1.27
开:1.27
低:1.27
收:1.27
52周最高:22.50
52周最低:0.9200
股本:6,029.27万
流通股本:1,288.63万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.8789
每股收益(LYR):-3.2355
净资产收益率:-47.82%
总资产收益率:2.89%
市净率:0.76
市盈率(LYR):-0.39

数据加载中...

2023/08/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/03

重要事件披露

Form 8-K - Current report
2023/07/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/29

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/28

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/27

重要事件披露

Form 8-K - Current report
2023/06/23

重要事件披露

Form 8-K - Current report
2023/06/22

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/06/22

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/06/21

重要事件披露

Form 8-K - Current report
2023/06/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/12

重要事件披露

8-K - Current report
2023/03/30

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/30

重要事件披露

8-K - Current report
2023/03/30

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/21

重要事件披露

8-K - Current report
2023/03/10

重要事件披露

8-K - Current report
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/06

重要事件披露

8-K - Current report